Treace Medical Concepts, Inc.
TMCI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630627
In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Treace Medical Concepts, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 138 | 2 | 125 | −11 |
| Shares | 37.9M | 651 | 38.4M | +498.2K (+1.3%) |
| Value | $315.3M | $5.46K | $226.1M | −$89.2M (−28.3%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Treace Medical Concepts, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CenterBook Partners LP | 562,710 | $3.31M | 0.18% |
| Paradigm Capital Management Inc | 268,161 | $1.58M | 0.08% |
| Squarepoint Ops LLC | 48,972 | $288.0K | 0.00% |
| Skopos Labs, Inc. | 38,982 | $229.2K | 0.03% |
| Algert Global LLC | 32,880 | $193.3K | 0.00% |
| Sanctuary Advisors, LLC | 22,375 | $131.6K | 0.00% |
| Qube Research & Technologies Ltd | 17,408 | $102.4K | 0.00% |
| Graham Capital Management, L.P. | 15,748 | $92.6K | 0.00% |
| Commonwealth Equity Services, LLC | 13,789 | $81.0K | 0.00% |
| Captrust Financial Advisors | 10,565 | $62.1K | 0.00% |
| LPL Financial LLC | 10,500 | $61.7K | 0.00% |
| Lazard Asset Management LLC | 5,190 | $30.0K | 0.00% |
| Farther Finance Advisors, LLC | 4,717 | $27.7K | 0.00% |
| MTM Investment Management, LLC | 1,330 | $7.82K | 0.00% |
| Quarry LP | 817 | $4.80K | 0.00% |
| Essential Partners LLC | 283 | $1.66K | 0.00% |
| IFP Advisors, Inc | 241 | $1.42K | 0.00% |
| Larson Financial Group LLC | 14 | $82 | 0.00% |
| Clearstead Advisors, LLC | 10 | $59 | 0.00% |
Sold out (30)
Institutions that held Treace Medical Concepts, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
Not filed for Q2 2025 yet (2)
Institutions that held Treace Medical Concepts, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 401 | $3.36K |
| Davis Capital Management | 250 | $2.10K |